
Human Immunoglobulin gamma-1 heavy chain 253-261, LMISRTPEV
Description
About Human Immunoglobulin gamma-1 heavy chain 253-261, LMISRTPEV
The Human Immunoglobulin gamma-1 heavy chain Peptide (IEDB: 439064) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Immunoglobulin Peptide, H-LMISRTPEV-OH (Uniprot: P0DOX5 aa: 253-261) from JPT is produced under strict quality control and quality management.
Human Immunoglobulin gamma-1 heavy chain 253-261, LMISRTPEV - Specifications
- Peptide sequence: H-LMISRTPEV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Breast cancer
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Immunoglobulin gamma-1 heavy chain 253-261, LMISRTPEV
References:
Read References with JPT’s Antigen Peptides
Human Immunoglobulin gamma-1 heavy chain 253-261, LMISRTPEV has been described in:
Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome., PLoS One, 2015 (PMID: 26375851)
An open-source computational and data resource to analyze digital maps of immunopeptidomes., Elife, 2015 (PMID: 26154972)
Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas., Neuro Oncol, 2016 (PMID: 26984745)
Documentation
Documentation for Human Immunoglobulin gamma-1 heavy chain 253-261, LMISRTPEV
Properties
Properties of Human Immunoglobulin gamma-1 heavy chain 253-261, LMISRTPEV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Breast cancer |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Protein Name: | Immunoglobulin |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Immunoglobulin gamma-1 heavy chain 253-261, LMISRTPEV
Information | Values |
---|---|
Sequence: | H-LMISRTPEV-OH |
Specifications: | 9mer peptide as TFA salt |